Effect of chitosan on dextran sulfate sodium sulfate-induced ulcerative colitis in mice

Yue ZHANG,Zhong-yin ZHOU,Lu CHEN,He-sheng LUO
DOI: https://doi.org/10.3969/j.issn.1671-038X.2017.11.09
2017-01-01
Abstract:[Objective]To investigate the effect of chitosan on acute inflammatory response in mice dextran sulfate sodium-induced colitis,and the potential mechanism.[Methods]Forty Balb/c mice were divided into four groups,including normal control,DSS,Chitosan and 5-ASA,randomly.The mice in DSS,5-ASA and Chitosan groups were orally administered with 3% DSS solution for 7 days to induce acute colitis,constructing ulcerative colitis model.During the experimental period,the mice were given corresponding drug lavage treatment.Clinical signs,body weight,stool consistency and fecal blood were observed every day.At the end of the experiment,the colonic myeloperoxidase (MPO)activity were measured.[Results] 3% DSS successfully induced acute colitis associated with diarrhea,mucopurulent bloody stool,and body weight decreasing.Chitosan effectively improved the symptoms of UC induced by DSS,and reduced MPO activity in colonic tissue(6.108±1.893 U/g vs 3.502±0.529 U/g,P<0.01),increased the colon length.And the HE staining of the degree of inflammation and disease activity index were significantly improved.[Conclusion]Chitosan can effectively treat DSS-induced acute colitis through the induction of specific immune response,reducing the inflammatory response and enhancing the immune response.The Chitosan is expected to be a potential drug for the treatment of ulcerative colitis.
What problem does this paper attempt to address?